Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Evident Vascular in the transaction. Evident Vascular announced it has launched its $35 million Series A financing led by Vensana...
Evident Vascular’s $35 Million Series A Financing
Headway’s $125 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Spark Capital in the transaction. The healthcare tech startup, Headway announced it has raised $125 million in Series C...
TCV Lead Instawork’s $60M Series D Financing
Gunderson Dettmer represented client TCV on the deal. Instawork, the leading platform for connecting businesses with skilled hourly workers, has announced it has raised $60 million in...
Photys Therapeutics’ $75 Million Series A Financing
Gunderson Dettmer advised Photys Therapeutics on the deal. Photys Therapeutics, a developer of phosphorylation-inducing chimeric small molecule (PHICS) medicines, announced its $75 million Series A financing...
Afresh’s $115 Million Series B Financing
Gunderson Dettmer represented Spark Capital on the deal. Spark Capital led the $115 million Series B financing of Afresh, an AI-powered fresh food technology provider that...
Carbon Biosciences’ $38 Million Series A Financing
Gunderson Dettmer represented Carbon Biosciences on the deal. Carbon Biosciences, a developer of novel parvovirus-derived gene therapies, announced its emergence from stealth mode and the closing of...